Table 1 Demographic and clinical characteristics of the patients at baseline.
From: Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
Characteristics | All Patients | RDV | RDV + CORT | p |
|---|---|---|---|---|
n = 374 | n = 184 | n = 190 | ||
Age | ||||
Mean (years ± SD) | 67.3 ± 15.3 | 65.8 ± 15.2 | 68.8 ± 15.3 | .59 |
Distribution (n; %) | .14 | |||
< 40 | 16 (4.3) | 10 (5.4) | 6 (3.2) | |
40—64 | 127 (34.0) | 71 (38.6) | 56 (29.5) | |
≥ 65 | 231 (61.7) | 103 (56.0) | 128 (67.4) | |
Sex (n; %) | .65 | |||
Female | 120 (32.1) | 57 (31.0) | 63 (33.2) | |
Male | 254 (67.9) | 127 (69.0) | 127 (66.8) | |
Body-mass index (n/total; %) | .1 | |||
Normal/Underweight (< 25) | 106/297 (35.7) | 61/152 (40.1) | 45/145 (31.0) | |
Obese/Overweight (≥ 25) | 191/297 (64.3) | 91/152 (59.9) | 100/145 (69.0) | |
Time from symptom onset to RDV (days; SD) | n = 354 | n = 173 | n = 181 | |
Mean | 7.2 ± 4.2 | 7.0 ± 3.9 | 7.3 ± 4.4 | .1 |
Length of Therapy (days; SD) | ||||
Mean | 6.2 ± 2.5 | 5.8 ± 2.2 | 6.7 ± 2.6 | < .001 |
Score on ordinal scale—(n; %) | .016 | |||
5 | 298 (79.7) | 158 (85.9) | 140 (73.7) | |
6 | 25 (6.7) | 6 (3.3) | 19 (10) | |
7 | 51 (13.6) | 20 (10.9) | 31 (16.3) | |
Mortality (n; %) | 52 (13.9) | 23 (12.5) | 29 (15.2) | .459 |
